Funded Startups in Planegg
Planegg’s most recently disclosed rounds are concentrated in the 2023–2025 window, spanning from 2022-01-07 (Electrochaea, Series D, $41M) to 2025-09-10 (A…
Planegg’s most recently disclosed rounds are concentrated in the 2023–2025 window, spanning from 2022-01-07 (Electrochaea, Series D, $41M) to 2025-09-10 (AMSilk, Venture - Series Unknown, $35M). On disclosed amounts, Electrochaea’s $41M stands out as the highest, and it sits above the next-largest disclosed round at $35M (AMSilk, 2025-09-10), with the rest largely in the $11M–$29M range.
Sector and stage patterns are also tight: 6 of 7 companies are in Biotechnology (AMSilk 2025-09-10 $35M; ETHRIS 2025-05-06 $11M; CPTx 2024-09-12 $29M; Insempra 2024-05-08 $20M; Bind-X 2023-08-01 $11M; mk2 Biotechnologies 2023-06-06 undisclosed), with Energy represented only once (Electrochaea, 2022-01-07). Stage labeling is dominated by “Series Unknown” (5 of 7 rows), while only 2 rows specify named stages (Insempra’s Series A at $20M and Bind-X’s Series B at $11M), and one row is explicitly undisclosed (mk2 Biotechnologies).
Most recent rounds
7 shownRelated listings
Frequently asked
Which disclosed round is largest in Planegg, and how much higher is it than the rest?
Electrochaea’s $41M (2022-01-07, Series D) is the top disclosed amount in this set, followed closely by AMSilk’s $35M (2025-09-10). The remaining disclosed rounds are $29M (CPTx, 2024-09-12), $20M (Insempra, 2024-05-08), and two $11M rounds (ETHRIS 2025-05-06; Bind-X 2023-08-01).
Is there a concentration in time, or are rounds spread evenly across the period shown?
Most of the activity clusters in 2023–2025: 6 of 7 rows fall between 2023-06-06 (mk2 Biotechnologies) and 2025-09-10 (AMSilk). Only one entry lands earlier, Electrochaea at $41M on 2022-01-07.
Does any sector dominate these Planegg-funded entries?
Yes. Biotechnology accounts for 6 of the 7 companies (AMSilk, ETHRIS, CPTx, Insempra, Bind-X, mk2 Biotechnologies), leaving Energy represented only once by Electrochaea’s $41M (2022-01-07).
How often are stage labels specified versus left unknown or undisclosed?
Stage information is mostly missing or incomplete: 5 of 7 rows list “Series Unknown” (AMSilk 2025-09-10 $35M; ETHRIS 2025-05-06 $11M; CPTx 2024-09-12 $29M; mk2 Biotechnologies 2023-06-06 undisclosed; and another “Series Unknown” entry at 2023-06-06). Only 2 rows specify named stages with disclosed amounts: Insempra’s Series A ($20M) and Bind-X’s Series B ($11M).
Are there outliers in sector or disclosed amount that would merit extra diligence?
Electrochaea’s $41M (2022-01-07, Energy) is the disclosed amount outlier relative to the rest’s $11M–$35M band. The other notable outlier is mk2 Biotechnologies (2023-06-06), which is categorized as Biotechnology but has an explicitly “undisclosed” amount.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.